CLINICAL_TRIALS
trial_result
· 2015-05-04
Clinical Trial Update: Fingolimod (FTY720) in Acute Demyelinating Optic Neuritis (ADON) [Phase 2]
Summary
Phase 2 trial evaluating Fingolimod for acute demyelinating optic neuritis; the study was terminated and results were posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Acute Demylelinating Optic Neuritis | Phase 2 | Status: TERMINATED | Results posted: 2015-05-04